Kamiya, Daisuke
Takenaka-Ninagawa, Nana
Motoike, Souta
Kajiya, Mikihito http://orcid.org/0000-0001-6652-0007
Akaboshi, Teppei
Zhao, Chengzhu
Shibata, Mitsuaki
Senda, Sho
Toyooka, Yayoi
Sakurai, Hidetoshi http://orcid.org/0000-0002-5383-9366
Kurihara, Hidemi
Ikeya, Makoto http://orcid.org/0000-0002-3930-8032
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (16H05447, 18H02977)
Takeda Pharmaceutical Company
the iPS Cell Research Fund
Japan Agency for Medical Research and Development
Article History
Received: 29 April 2021
Accepted: 8 August 2022
First Online: 15 September 2022
Competing interests
: S.S. is an employee of Ajinomoto Co., Inc., M.I. is supported by a research fund from Ajinomoto Co., Inc. D.K., Y.T., and M.I. are supported by a research fund from Takeda Pharmaceutical Company Limited. The remaining authors declare no competing interests.